尼达尼布对进展性纤维化间质性肺疾病(ILDs)患者强制肺活量(FVC)下降的影响

{"title":"尼达尼布对进展性纤维化间质性肺疾病(ILDs)患者强制肺活量(FVC)下降的影响","authors":"M. Strek, R. Hallowell, J. Kuś, H. Nunes, T. Suda, S. Tomassetti, H. Mueller, K. Rohr, K. Flaherty, on behalf of the INBUILD trial investigators","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1907","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Time Since Diagnosis\",\"authors\":\"M. Strek, R. Hallowell, J. Kuś, H. Nunes, T. Suda, S. Tomassetti, H. Mueller, K. Rohr, K. Flaherty, on behalf of the INBUILD trial investigators\",\"doi\":\"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1907\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":333033,\"journal\":{\"name\":\"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1907\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1907","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}